Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed?
Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed? – The Conversation
The post Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed? appeared first on Links Medicus.
Essay: Tuberculosis in times of COVID-19.
Tuberculosis in times of COVID-19 – Journal of Epidemiology & Community Health Related: Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery. Global tuberculosis progress reversed by COVID-19 pandemic. WHO Report: Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic. How COVID is derailing the […]
The post Essay: Tuberculosis in times of COVID-19. appeared first on Links Medicus.
Data Review: How many people die from air pollution?
Data Review: How many people die from air pollution? – Our World in Data Related: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution. Short-term exposure to ambient air pollution is associated with increased risk of myocardial infarction mortality 1.8 million excess deaths attributable to urban air pollution in […]
The post Data Review: How many people die from air pollution? appeared first on Links Medicus.
ED management of the post-laryngectomy patient.
ED Management of the Post-Laryngectomy Patient – emDocs
The post ED management of the post-laryngectomy patient. appeared first on Links Medicus.
Review: Management of venous thromboembolism in pregnancy.
Management of venous thromboembolism in pregnancy – Thrombosis Research Related: Management of high-risk pulmonary embolism in pregnancy. Study: Diagnosis of Pulmonary Embolism During Pregnancy Imaging is the only way to diagnose blood clots in pregnancy Prevention and Treatment of Pregnancy-Associated Venous Thromboembolism: Critical Appraisal of International Guidelines
The post Review: Management of venous thromboembolism in pregnancy. appeared first on Links Medicus.
RCT: In patients with cardiogenic shock receiving VA-ECMO, moderate hypothermia did not significantly reduce 30-day mortality. 42% of patients in the moderate hypothermia group died vs. 51% in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.4
Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text) Commentary: Hypothermia vs. Normothermia for Cardiogenic Shock Patients on VA-ECMO – American College of Cardiology Commentary on Twitter In this RCT, for […]
The post RCT: In patients with cardiogenic shock receiving VA-ECMO, moderate hypothermia did not significantly reduce 30-day mortality. 42% of patients in the moderate hypothermia group died vs. 51% in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.45 to 1.13], P = .15). appeared first on Links Medicus.
ERS statement on Long COVID-19 follow-up.
European Respiratory Society Statement on Long COVID-19 Follow-Up – European Respiratory Review
The post ERS statement on Long COVID-19 follow-up. appeared first on Links Medicus.
Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant.
Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant – STAT Related: FDA halts use of antibody drugs that don’t work vs. Omicron. Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
The post Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant. appeared first on Links Medicus.
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension.
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension – European Respiratory Review
The post WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension. appeared first on Links Medicus.
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments.
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments – European Respiratory Review
The post Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments. appeared first on Links Medicus.